Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data Boston, MA, USA, Lausanne, SWITZERLAND, and Tokyo, JAPAN --- SOPHiA GENETICS SA (“SOPHiA GENETICS”), pioneer in Data-Driven Medicine, and Hitachi, Ltd. (TSE:6501, "Hitachi") today announced they have entered into a long-term collaboration agreement to bring [...]

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif. -- Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance [...]

Effectively doubles Bay Area facilities, with increased R&D space and newly opened Customer Experience Center SANTA CLARA, Calif. – Rebus Biosystems, Inc., a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise, today announced the appointment of Neil Kennedy as Chief Commercial Officer (CCO) and Scott Kothlow as Chief Financial Officer (CFO). This news comes [...]

Multi-year study will use Congenica’s platform for rapid and accurate genomic analysis Sioux Falls, South Dakota, United States and Cambridge, UK – Sanford Health (‘Sanford’), a leading US-based healthcare delivery system provider and Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peoples’ lives, today announce a genomics partnership focused on [...]

NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms [...]

Guildford, UK  — IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), today announced the launch of Polar BioAnalysis, bringing consistency, quality, and reproducibility to preclinical drug qualification. Polar BioAnalysis expands the capabilities of IDBS Polar, a cloud-based platform designed to solve workflow, quality, and data analysis challenges across the entire development lifecycle. By combining [...]

Strong financial performance and the achievement of other key milestones demonstrate the growing strength of Synthace’s offering within the biopharma and biotech industries London, UK: Synthace Ltd, developers of Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced it increased its annual recurring revenue by 225% compared [...]

ROCHESTER, Minn. ― Mayo Clinic and Thermo Fisher Scientific have joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The Advanced Diagnostics Laboratory in One Discovery Square, which is part of the Destination Medical Center initiative, will be the home [...]

SOUTH SAN FRANCISCO, Calif. & LA JOLLA, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research, Inc., a subsidiary of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: [...]

NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets NanoTemper Technologies announced a partnership with PharmAI, the Dresden-based start-up that specializes in virtual screening software. Together, they will zero in on one of the biggest roadblocks to quick drug development: Researchers have to comb through [...]